Miura T, Klaus W, Gsell B, Miyamoto C, Senn H
Pharma Preclinical Research Department, F. Hoffmann-La Roche AG, Basel, CH-4070, Switzerland.
J Mol Biol. 1999 Jul 2;290(1):213-28. doi: 10.1006/jmbi.1999.2859.
Ubiquitin-conjugating enzymes (Ubc) are involved in ubiquitination of proteins in the protein degradation pathway of eukaryotic cells. Ubc transfers the ubiquitin (Ub) molecules to target proteins by forming a thioester bond between their active site cysteine residue and the C-terminal glycine residue of ubiquitin. Here, we report on the NMR assignment and secondary structure of class I human ubiquitin-conjugating enzyme 2b (HsUbc2b). Chemical shift perturbation studies allowed us to map the contact area and binding interface between ubiquitin and HsUbc2b by1H-15N HSQC NMR spectroscopy. The serine mutant of the active site Cys88 of HsUbc2b was employed to obtain a relatively stable covalent ubiquitin complex of HsUbc2b(C88S). Changes in chemical shifts of amide protons and nitrogen atoms induced by the formation of the covalent complex were measured by preparing two segmentally labeled complexes with either ubiquitin or HsUbc2b(C88S)15N-labeled. In ubiquitin, the interaction is primarily sensed by the C-terminal segment Val70 - Gly76, and residues Lys48 and Gln49. The surface area on ubiquitin, as defined by these residues, overlaps partially with the presumed binding site with ubiquitin-activating enzyme (E1). In HsUbc2b, most of the affected residues cluster in the vicinity of the active site, namely, around the active site Cys88 itself, the second alpha-helix, and the flexible loop which connects helices alpha2 and alpha3 and which is adjacent to the active site. An additional site on HsUbc2b for a weak interaction with ubiquitin could be detected in a titration study where the two proteins were not covalently linked. This site is located on the backside of HsUbc2b opposite to the active site and is part of the beta-sheet. The covalent and non-covalent interaction sites are clearly separated on the HsUbc2b surface, while no such clear-cut segregation of the interaction area was observed on ubiquitin.
泛素缀合酶(Ubc)参与真核细胞蛋白质降解途径中蛋白质的泛素化过程。Ubc通过在其活性位点半胱氨酸残基与泛素的C末端甘氨酸残基之间形成硫酯键,将泛素(Ub)分子转移到靶蛋白上。在此,我们报告了I类人泛素缀合酶2b(HsUbc2b)的核磁共振(NMR)归属及二级结构。化学位移扰动研究使我们能够通过1H-15N HSQC NMR光谱法绘制泛素与HsUbc2b之间的接触区域和结合界面。使用HsUbc2b活性位点Cys88的丝氨酸突变体来获得相对稳定的HsUbc2b(C88S)共价泛素复合物。通过制备分别用泛素或15N标记的HsUbc2b(C88S)进行片段标记的两种复合物,测量了共价复合物形成引起的酰胺质子和氮原子化学位移的变化。在泛素中,相互作用主要由C末端片段Val70 - Gly76以及残基Lys48和Gln49感知。由这些残基定义的泛素表面区域与泛素激活酶(E1)的假定结合位点部分重叠。在HsUbc2b中,大多数受影响的残基聚集在活性位点附近,即围绕活性位点Cys88本身、第二个α螺旋以及连接α2和α3螺旋且与活性位点相邻的柔性环。在两种蛋白质未共价连接的滴定研究中,可以检测到HsUbc2b上与泛素有弱相互作用的另一个位点。该位点位于HsUbc2b与活性位点相对的背面,是β折叠的一部分。共价和非共价相互作用位点在HsUbc2b表面明显分开,而在泛素上未观察到相互作用区域如此明确的分隔。